Atossa_Therapeutics_logo-min.png
Atossa Therapeutics to Present at the Maxim Group 2022 Virtual Growth Conference
23 mars 2022 09h30 HE | Atossa Therapeutics, Inc.
SEATTLE, March 23, 2022 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative medicines in oncology and infectious...